ATA52280A - Verfahren zur herstellung einer hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure - Google Patents

Verfahren zur herstellung einer hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure

Info

Publication number
ATA52280A
ATA52280A AT0052280A AT52280A ATA52280A AT A52280 A ATA52280 A AT A52280A AT 0052280 A AT0052280 A AT 0052280A AT 52280 A AT52280 A AT 52280A AT A52280 A ATA52280 A AT A52280A
Authority
AT
Austria
Prior art keywords
acetamidocephalospo
aminothiazolyl
producing
sodium salt
crystalline form
Prior art date
Application number
AT0052280A
Other languages
English (en)
Other versions
AT366050B (de
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA52280(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ATA52280A publication Critical patent/ATA52280A/de
Application granted granted Critical
Publication of AT366050B publication Critical patent/AT366050B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0052280A 1977-08-17 1980-01-31 Verfahren zur herstellung einer hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure AT366050B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
AT0563578A AT366049B (de) 1977-08-17 1978-08-03 Verfahren zur herstellung der hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure

Publications (2)

Publication Number Publication Date
ATA52280A true ATA52280A (de) 1981-07-15
AT366050B AT366050B (de) 1982-03-10

Family

ID=9194564

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0563578A AT366049B (de) 1977-08-17 1978-08-03 Verfahren zur herstellung der hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure
AT0052280A AT366050B (de) 1977-08-17 1980-01-31 Verfahren zur herstellung einer hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0563578A AT366049B (de) 1977-08-17 1978-08-03 Verfahren zur herstellung der hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure

Country Status (34)

Country Link
US (1) US4224371A (de)
EP (1) EP0001024B1 (de)
JP (1) JPS5441890A (de)
AT (2) AT366049B (de)
AU (1) AU520898B2 (de)
BG (2) BG33888A3 (de)
CA (1) CA1121343A (de)
CS (2) CS207646B2 (de)
DD (1) DD137588A5 (de)
DE (1) DE2860358D1 (de)
DK (2) DK152213C (de)
EG (1) EG13520A (de)
ES (1) ES472381A1 (de)
FI (1) FI65433C (de)
FR (1) FR2400519A1 (de)
GE (2) GEP19960475B (de)
GR (1) GR73661B (de)
HR (1) HRP931395B1 (de)
HU (1) HU181497B (de)
IE (1) IE47230B1 (de)
IL (1) IL55186A (de)
IT (1) IT1107961B (de)
MD (2) MD225C2 (de)
MX (2) MX155976A (de)
NO (1) NO156168C (de)
NZ (1) NZ188163A (de)
OA (1) OA06016A (de)
PL (1) PL126619B1 (de)
PT (1) PT68431A (de)
RO (1) RO79999A (de)
SI (1) SI7811917A8 (de)
SU (2) SU799666A3 (de)
YU (1) YU42166B (de)
ZA (1) ZA784187B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
ATE138664T1 (de) * 1985-08-12 1996-06-15 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
JPS6145626B2 (de) 1986-10-08
BG33888A3 (en) 1983-05-16
NO156168C (no) 1987-08-19
FR2400519A1 (fr) 1979-03-16
MX5448E (es) 1983-08-09
DE2860358D1 (en) 1981-03-12
FI65433C (fi) 1984-05-10
DK159786D0 (da) 1986-04-09
ES472381A1 (es) 1979-03-16
EP0001024A1 (de) 1979-03-07
DD137588A5 (de) 1979-09-12
GEP19960475B (en) 1996-07-22
DK163514C (da) 1992-07-27
JPS5441890A (en) 1979-04-03
OA06016A (fr) 1981-06-30
NO156168B (no) 1987-04-27
IL55186A0 (en) 1978-09-29
YU42166B (en) 1988-06-30
AT366049B (de) 1982-03-10
IE47230B1 (en) 1984-01-25
IL55186A (en) 1981-07-31
NZ188163A (en) 1981-10-19
ATA563578A (de) 1981-07-15
SI7811917A8 (en) 1997-12-31
BG33887A3 (en) 1983-05-16
PT68431A (fr) 1978-09-01
MD247B1 (ro) 1995-07-31
SU852175A3 (ru) 1981-07-30
AU3896578A (en) 1980-02-21
YU191778A (en) 1983-02-28
GEP19960476B (en) 1996-07-22
DK361078A (da) 1979-02-18
MD225C2 (ro) 1995-12-31
AT366050B (de) 1982-03-10
DK163514B (da) 1992-03-09
EP0001024B1 (de) 1981-01-21
IT1107961B (it) 1985-12-02
EG13520A (en) 1982-03-31
ZA784187B (en) 1979-09-26
FI782494A (fi) 1979-02-18
DK152213C (da) 1988-07-11
IE781669L (en) 1979-02-17
GR73661B (de) 1984-03-28
DK159786A (da) 1986-04-09
CS207646B2 (en) 1981-08-31
CS207647B2 (en) 1981-08-31
RO79999A (ro) 1982-10-11
CA1121343A (fr) 1982-04-06
HRP931395B1 (en) 1996-04-30
FI65433B (fi) 1984-01-31
MD225B1 (ro) 1995-06-30
MX155976A (es) 1988-06-06
US4224371A (en) 1980-09-23
AU520898B2 (en) 1982-03-04
PL209080A1 (pl) 1979-06-04
PL126619B1 (en) 1983-08-31
SU799666A3 (ru) 1981-01-23
FR2400519B1 (de) 1980-05-16
IT7850648A0 (it) 1978-08-08
HU181497B (en) 1983-07-28
DK152213B (da) 1988-02-08
MD247C2 (ro) 1995-12-31
NO782782L (no) 1979-02-20

Similar Documents

Publication Publication Date Title
ATA52280A (de) Verfahren zur herstellung einer hydratisierten kristallinen form des natriumsalzes eines oximderivates der 7-aminothiazolylacetamidocephalospo-ransaeure
AT364853B (de) Verfahren zur herstellung eines mono- oder disalzes des n-phosphonomethylglycins
AT362082B (de) Verfahren zur herstellung eines desinfektions- mittels
AT369014B (de) Verfahren zur herstellung physiologisch vertraeglicher salze der phosphonoameisensaeure
AT358015B (de) Verfahren zur herstellung einer 2-arylpropion- saeure
ATA384878A (de) Verfahren zur herstellung eines nicht- hygroskopischen lactulosehaeltigen pulvers
AT370625B (de) Verfahren zur herstellung einer stabilen waesserigen injektionsloesung eines oxytetracyclin- -erdalkalimetall-chelats
AT363600B (de) Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes
ATA506477A (de) Verfahren zur herstellung einer hydroxyver- bindung
SU725555A3 (en) Method of preparing 2-hydrazonopropionic acid derivatives or their salts
ATA449178A (de) Verfahren zur herstellung eines keramischen gegenstandes
AT348676B (de) Verfahren zur herstellung einer kristall- modifikation des natriumsalzes von 7-cyanacetylamino-cephalosporansaeure
ATA883578A (de) Verfahren zur herstellung einer heterovakzine
AT361640B (de) Verfahren zur herstellung neuer 3beta-substi- tuierter 18-beta-olean-9-en-30-oylsaeure- derivate
AT364462B (de) Verfahren zur herstellung einer kristallinen form eines cefamandolderivates
AT367427B (de) Verfahren zur herstellung neuer kristalliner additionssalze
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
AT344676B (de) Verfahren zur herstellung einer perpropionsaeureloesung
AT363588B (de) Verfahren zur herstellung einer stabilen sauren sekretinzubereitung
AT363956B (de) Verfahren zur herstellung einer heterocyclischen verbindung
AT367753B (de) Verfahren zur herstellung neuer benzimidazolderivat-salze
ATA653079A (de) Verfahren zur herstellung einer b-beta- -acylaminopenicillansaeure
DD137099A5 (de) Verfahren zur herstellung einer 2-arylpropionsaeure
DD131145A1 (de) Verfahren zur herstellung einer metall-keramik-verbindung
DD136196A1 (de) Verfahren zur herstellung einer blockwicklung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELA Expired due to lapse of time